Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Esophageal Neoplasms"" wg kryterium: Temat


Tytuł:
Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study.
Autorzy:
Kroese TE; Department of Radiation Oncology, University Hospital Zurich, University Zurich, Switzerland; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, The Netherlands; Department of Surgery, University Medical Center Utrecht, Utrecht University, The Netherlands.
Christ SM; Department of Radiation Oncology, University Hospital Zurich, University Zurich, Switzerland.
van Rossum PSN; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, The Netherlands.
Burger MDL; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, The Netherlands; Department of Surgery, University Medical Center Utrecht, Utrecht University, The Netherlands.
Buijs GS; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, The Netherlands; Department of Surgery, University Medical Center Utrecht, Utrecht University, The Netherlands.
Mühlematter U; Department of Nuclear Medicine, University Hospital Zurich, University Zurich, Switzerland.
Andratschke N; Department of Radiation Oncology, University Hospital Zurich, University Zurich, Switzerland.
Ruurda JP; Department of Surgery, University Medical Center Utrecht, Utrecht University, The Netherlands.
Hüllner M; Department of Nuclear Medicine, University Hospital Zurich, University Zurich, Switzerland.
Gutschow CA; Department of Surgery and Transplantation, University Hospital Zurich, University Zurich, Switzerland.
van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht University, The Netherlands.
Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Aug; Vol. 173, pp. 269-276. Date of Electronic Publication: 2022 Jun 24.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Esophageal Neoplasms*/pathology
Esophageal Neoplasms*/therapy
Neoplasms, Second Primary*
Radiosurgery*/methods
Stomach Neoplasms*/therapy
Humans ; Incidence ; Neoplasm Recurrence, Local ; Positron Emission Tomography Computed Tomography ; Retrospective Studies
Czasopismo naukowe
Tytuł:
[China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)].
Autorzy:
He J; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Chen WQ; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Li ZS; Changhai Hospital, Shanghai 200433, China.
Li N; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Ren JS; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Tian JH; Evidence-Based Medicine Center, Lanzhou University, Lanzhou 730000, China.
Tian WJ; Public Health College of Harbin Medical University, Harbin 150081, China.
Hu FL; School of Public Health, Shenzhen University Health Science Center, Shenzhen 518037, China.
Peng J; Shenzhen Centre for Chronic Disease Control, Shenzhen 518020, China.
Pokaż więcej
Corporate Authors:
Expert Group of China Guideline for the Screening, Early Detection and Early Treatment of Esophageal Cancer
Work Group of China Guideline for the Screening,Early Detection and Early Treatment of Esophageal Cancer
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 Jun 23; Vol. 44 (6), pp. 491-522.
Typ publikacji:
Journal Article
MeSH Terms:
Early Detection of Cancer*/methods
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/prevention & control
Beijing ; China/epidemiology ; Humans ; Mass Screening
Czasopismo naukowe
Tytuł:
MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients.
Autorzy:
Kahng DH; Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea.
Kim GH; Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. .
Park SJ; Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
Kim S; Department of Convergence Medical Sciences, Pusan National University Graduate School of Medicine, Yangsan, Korea.
Lee MW; Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea.
Lee BE; Department of Internal Medicine, Pusan National University College of Medicine, Busan, Korea.
I H; Department of Thoracic Surgery, Pusan National University College of Medicine, Busan, Korea.
Pokaż więcej
Źródło:
Journal of Korean medical science [J Korean Med Sci] 2022 Jun 20; Vol. 37 (24), pp. e197. Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/genetics
Esophageal Squamous Cell Carcinoma*/diagnosis
Esophageal Squamous Cell Carcinoma*/genetics
MicroRNAs*/genetics
Biomarkers, Tumor/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Prognosis
Czasopismo naukowe
Tytuł:
Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Autorzy:
Yang L; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China; First Department of Lung Cancer Chemotherapy, Cancer Hospital Affiliated of Xinjiang Medical University, Urumqi 830000, China.
Salai A; Second Ward of Thoracic Surgery, Cancer Hospital Affiliated of Xinjiang Medical University, Urumqi 830000, China.
Sun X; First Ward of Thoracic Surgery, Cancer Hospital Affiliated of Xinjiang Medical University, Urumqi 830000, China.
Liu Q; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Liu T; Department of Clinical Laboratory, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Zhang Q; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Tuerxun A; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Tan Y; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Zheng S; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China. Electronic address: .
Lu X; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China. Electronic address: .
Pokaż więcej
Źródło:
Journal of proteomics [J Proteomics] 2022 Aug 15; Vol. 265, pp. 104662. Date of Electronic Publication: 2022 Jun 18.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/metabolism
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*/diagnosis
Esophageal Squamous Cell Carcinoma*/metabolism
Esophageal Squamous Cell Carcinoma*/pathology
Exosomes*/metabolism
Kangai-1 Protein*/metabolism
Biomarkers, Tumor ; Cell Line, Tumor ; Chromatography, Liquid ; Humans ; Prognosis ; Proteomics ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł:
CSMD1 suppresses cancer progression by inhibiting proliferation, epithelial-mesenchymal transition, chemotherapy-resistance and inducing immunosuppression in esophageal squamous cell carcinoma.
Autorzy:
Wang X; Translational Medicine Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 201620, Shanghai, China.
Chen X; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Liu Y; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Huang S; National Engineering Research Center for Nanomedicine, Key Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and Technology, Tongji Hospital, Huazhong University of Science and Technology, 430074, Wuhan, China.
Ding J; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Wang B; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Dong P; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
Sun Z; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. Electronic address: .
Chen L; Department of Otolaryngology: Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. Electronic address: .
Pokaż więcej
Źródło:
Experimental cell research [Exp Cell Res] 2022 Aug 15; Vol. 417 (2), pp. 113220. Date of Electronic Publication: 2022 May 25.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/genetics
Carcinoma, Squamous Cell*/metabolism
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Esophageal Squamous Cell Carcinoma*/drug therapy
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/metabolism
Animals ; CD8-Positive T-Lymphocytes/pathology ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation ; Cytokines/metabolism ; Epithelial-Mesenchymal Transition/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Immunosuppression Therapy ; Membrane Proteins/metabolism ; Mice ; Tumor Suppressor Proteins/metabolism
Czasopismo naukowe
Tytuł:
Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
Autorzy:
Liu Y; Department of Graduate, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Zheng Z; Department of Radiation Oncology, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology, Anyang, China.
Li M; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Zhang Y; Department of Radiation Oncology, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology, Anyang, China.
Zhao F; Department of Radiation Oncology, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology, Anyang, China.
Gong H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Lin H; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Huang W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Chen X; Department of Clinical Oncology, Taian City Central Hospital, Taian, Shandong, China.
Xu Z; Tumor Diagnosis and Treatment Center, Kaifeng Central Hospital, Kaifeng, Henan, China.
Li X; Department of Radiation Oncology, Shanxi Cancer Hospital, Taiyuan, Shanxi, China.
Liu W; Department of Clinical Oncology, Taian City Central Hospital, Taian, Shandong, China.
Cui Y; Radiation Therapy Department, 1 Ward of the First Affiliated Hospital of Xinxiang, Weihui, Henan, China.
Zheng A; Department of Radiation Oncology, Anyang Tumor Hospital, The Fourth Affiliated Hospital of Henan University of Science and Technology, Anyang, China.
Li B; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2022 Aug 15; Vol. 151 (4), pp. 607-615. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Carcinoma, Squamous Cell*/pathology
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/radiotherapy
Esophageal Squamous Cell Carcinoma*/drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemoradiotherapy/adverse effects ; Cisplatin/therapeutic use ; Epithelial Cells/pathology ; Humans
Czasopismo naukowe
Tytuł:
MiR-26b-5p in small extracellular vesicles derived from dying tumor cells after irradiation enhances the metastasis promoting microenvironment in esophageal squamous cell carcinoma.
Autorzy:
Yin X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Tian M; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210003, China. Electronic address: .
Zhang J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Tang W; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Feng L; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Li Z; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Zheng C; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Liu C; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Yan L; Clinical Medical College, Southwest Medical University, Luzhou, 646000, China. Electronic address: .
Yu X; Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China. Electronic address: .
Li B; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer letters [Cancer Lett] 2022 Aug 10; Vol. 541, pp. 215746. Date of Electronic Publication: 2022 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/metabolism
Esophageal Neoplasms*/radiotherapy
Esophageal Squamous Cell Carcinoma*/genetics
Esophageal Squamous Cell Carcinoma*/metabolism
Esophageal Squamous Cell Carcinoma*/radiotherapy
Extracellular Vesicles*/genetics
Extracellular Vesicles*/metabolism
MicroRNAs*/genetics
MicroRNAs*/metabolism
Tumor Microenvironment*/physiology
Tumor Microenvironment*/radiation effects
Animals ; Cell Line, Tumor/metabolism ; Cell Line, Tumor/radiation effects ; Humans ; Mice ; Phosphatidylinositol 3-Kinases/metabolism
Czasopismo naukowe
Tytuł:
Pericancerous lymph node imaging with indocyanine green-guided near-infrared fluorescence in radical esophagectomy: Protocol for a single-center, prospective, randomized controlled clinical trial.
Autorzy:
Du J; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery(Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.
Xu G; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery(Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.
Yang Z; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery(Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.
Zheng B; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery(Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.
Chen C; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Key Laboratory of Cardio-Thoracic Surgery(Fujian Medical University), Fujian Province University, Fuzhou, Fujian, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Aug; Vol. 13 (15), pp. 2283-2287. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/pathology
Esophageal Neoplasms*/surgery
Indocyanine Green*/pharmacology
Esophagectomy ; Humans ; Lymph Node Excision/methods ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Optical Imaging/methods ; Prospective Studies ; Randomized Controlled Trials as Topic ; Sentinel Lymph Node Biopsy/methods
Czasopismo naukowe
Tytuł:
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus.
Autorzy:
Li J; The Precision Medicine Centre of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China. Electronic address: jijilee_.
Guan W; The Pathology Department of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Ren W; The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University, Nanjing 210008, China.
Liu Z; The Precision Medicine Centre of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Wu H; The Pathology Department of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Chen Y; The Precision Medicine Centre of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Liu S; The Precision Medicine Centre of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Quan X; Geneplus-Shenzhen, Shenzhen 518118, China.
Yang Z; Geneplus-Shenzhen, Shenzhen 518118, China.
Jiang C; The Nuclear Medicine Department of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
He J; The Nuclear Medicine Department of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
Xiao X; Geneplus-Shenzhen, Shenzhen 518118, China. Electronic address: .
Ye Q; The Precision Medicine Centre of Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China; Department of Pathology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, China; Intelligent Pathology Institute, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, China. Electronic address: .
Pokaż więcej
Źródło:
Neoplasia (New York, N.Y.) [Neoplasia] 2022 Aug; Vol. 30, pp. 100811. Date of Electronic Publication: 2022 Jun 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Esophageal Neoplasms*/genetics
Esophageal Neoplasms*/pathology
Melanoma*/genetics
Melanoma*/pathology
DNA Copy Number Variations ; Genomics ; Humans ; Skin Neoplasms
SCR Disease Name:
Melanoma, Cutaneous Malignant
Czasopismo naukowe
Tytuł:
The anticancer effect of statins in obese esophageal cancer patients undergoing esophagectomy.
Autorzy:
Abdelfatah E; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Kukar M; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Mukherjee S; Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Groman A; Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Yendamuri S; Department of Thoracic Surgery, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Pokaż więcej
Źródło:
Journal of surgical oncology [J Surg Oncol] 2022 Aug; Vol. 126 (2), pp. 268-278. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/surgery
Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use
Esophagectomy/adverse effects ; Humans ; Obesity/complications ; Obesity/surgery ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Dr. Velanovich's contributions to understanding Barrett's Esophagus and its treatment.
Autorzy:
Sujka J; Department of Surgery, The University of South Florida Morsani College of Medicine, Tampa, FL, USA. Electronic address: .
DuCoin CG; Department of Surgery, The University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Pokaż więcej
Źródło:
American journal of surgery [Am J Surg] 2022 Aug; Vol. 224 (2), pp. 821-822. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:
Biography; Editorial; Historical Article
MeSH Terms:
Barrett Esophagus*/surgery
Esophageal Neoplasms*/etiology
Esophageal Neoplasms*/therapy
History, 20th Century ; History, 21st Century ; Humans
Personal Name as Subject:
Velanovich V
Opinia redakcyjna
Tytuł:
A case of finger metastasis from esophageal basaloid squamous cell carcinoma.
Autorzy:
Katsumata F; Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.
Kamiya K; Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.
Okada H; Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.
Maekawa T; Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.
Komine M; Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.
Ohtsuki M; Department of Dermatology, Jichi Medical University, Shimotsuke, Japan.
Pokaż więcej
Źródło:
International journal of dermatology [Int J Dermatol] 2022 Aug; Vol. 61 (8), pp. e302-e304. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Case Reports; Letter; Comment
MeSH Terms:
Carcinoma, Squamous Cell*/diagnosis
Carcinoma, Squamous Cell*/pathology
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/pathology
Esophageal Squamous Cell Carcinoma*
Humans
Raport
Tytuł:
Dose escalation based on F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12).
Autorzy:
Zhu H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Liu Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Xu H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Mo M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Cancer Prevention and Statistics, Fudan University Shanghai Cancer Center, Shanghai, China.
Wang Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Cancer Prevention and Statistics, Fudan University Shanghai Cancer Center, Shanghai, China.
Lu K; Department of Radiation Oncology, Taizhou Second People's Hospital, Taizhou, Jiangsu, China.
Zhou J; Department of Radiation Oncology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Chen J; Department of Radiation Oncology, Fujian Cancer Hospital, Fuzhou, China.
Zheng X; Department of Radiation Oncology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Ye J; Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing, China.
Ge X; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Luo H; Department of Radiation Oncology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
Liu Q; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Deng J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Ai D; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Hao S; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Zhang J; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Tseng IH; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China.
Song S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.; Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Chen Y; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. chenyun_.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. chenyun_.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China. chenyun_.
Zhao K; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. kuaile_.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. kuaile_.; Shanghai Key Laboratory of Radiation Oncology, Shanghai, China. kuaile_.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Jul 29; Vol. 17 (1), pp. 134. Date of Electronic Publication: 2022 Jul 29.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/therapy
Esophageal Squamous Cell Carcinoma*/therapy
Chemoradiotherapy ; China ; Fluorodeoxyglucose F18 ; Humans ; Positron Emission Tomography Computed Tomography/methods ; Prospective Studies ; Radiopharmaceuticals ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Restoring the perfusion of accidentally transected right gastroepiploic vessels during gastric conduit harvest for esophagectomy using microvascular anastomosis: a case report and literature review.
Autorzy:
Kou HW; Department of General Surgery, Chang Gung Memorial Hospital, Linkou Branch, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Huang PC; Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou Branch, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Cheong CF; Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Chao YK; Division of Thoracic Surgery, Chang Gung Memorial Hospital, Linkou Branch, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Tsai CY; Department of General Surgery, Chang Gung Memorial Hospital, Linkou Branch, College of Medicine, Chang Gung University, Taoyuan, Taiwan. .
Pokaż więcej
Źródło:
BMC surgery [BMC Surg] 2022 Jul 28; Vol. 22 (1), pp. 292. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Esophageal Neoplasms*/pathology
Esophageal Neoplasms*/surgery
Esophageal Squamous Cell Carcinoma*/surgery
Anastomosis, Surgical/methods ; Esophagectomy/methods ; Esophagogastric Junction/surgery ; Humans ; Ischemia/surgery ; Male ; Middle Aged ; Perfusion ; Stomach/pathology
Czasopismo naukowe
Tytuł:
Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy.
Autorzy:
Tang Z; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Zhu X; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Li Y; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Qu C; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Li L; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Li S; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Qi L; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Lu M; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Cheng C; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China.
Tian H; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, People's Republic of China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2022 Jul 25; Vol. 20 (1), pp. 239. Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article
MeSH Terms:
Enhanced Recovery After Surgery*
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/surgery
Esophagectomy/methods ; Feasibility Studies ; Humans ; Length of Stay ; Neoadjuvant Therapy/adverse effects ; Postoperative Complications/epidemiology ; Postoperative Complications/etiology ; Postoperative Complications/surgery ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
[The value and related complications of lymph node dissection along bilateral recurrent laryngeal nerves in esophageal cancer patients].
Autorzy:
Yuan LG; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Mao YS; Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2022 Jul 23; Vol. 44 (7), pp. 712-716.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/pathology
Thoracic Neoplasms*/pathology
Esophagectomy/adverse effects ; Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymph Nodes/surgery ; Lymphatic Metastasis/pathology ; Quality of Life ; Recurrent Laryngeal Nerve/pathology
Czasopismo naukowe
Tytuł:
Thoracic Duct Embolization for Delayed Chyle Leak After Lewis-Tanner Esophagectomy.
Autorzy:
Franceschilli M; Department of Surgery, University of Rome Tor Vergata, Rome, Italy.
Argirò R; Department of Diagnostic Imaging and Interventional Radiology, Tor Vergata University of Rome, Rome, Italy.
Siragusa L; Department of Surgery, University of Rome Tor Vergata, Rome, Italy.
Usai V; Department of Surgery, University of Rome Tor Vergata, Rome, Italy.
Sibio S; Department of Surgery 'Pietro Valdoni', University 'Sapienza' of Rome, Rome, Italy.
Di Carlo S; Department of Surgery, University of Rome Tor Vergata, Rome, Italy.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2022 Jul 22; Vol. 23, pp. e936590. Date of Electronic Publication: 2022 Jul 22.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Chyle*
Esophageal Neoplasms*/complications
Esophageal Neoplasms*/surgery
Chest Tubes/adverse effects ; Esophagectomy/adverse effects ; Humans ; Male ; Middle Aged ; Postoperative Complications/etiology ; Thoracic Duct/surgery
Czasopismo naukowe
Tytuł:
Identification of active components in Andrographis paniculata targeting on CD81 in esophageal cancer in vitro and in vivo.
Autorzy:
Yue GG; Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Gomes AJ; Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Saeed MEM; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, Mainz 55128, Germany.
Tsui KY; Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Dawood M; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, Mainz 55128, Germany.
Drif AI; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, Mainz 55128, Germany.
Wong EC; Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Lee WF; Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Liu W; Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Chiu PW; Department of Surgery, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
Efferth T; Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, Mainz 55128, Germany. Electronic address: .
Lau CB; Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong; State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong. Electronic address: .
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2022 Jul 20; Vol. 102, pp. 154183. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Journal Article
MeSH Terms:
Andrographis*/chemistry
Diterpenes*/chemistry
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/pathology
Andrographis paniculata ; Animals ; Humans ; Mice ; Molecular Docking Simulation ; Plant Extracts/chemistry ; Tetraspanin 28
Czasopismo naukowe
Tytuł:
Application Value of the Diagnosis during Early Carcinoma of Upper Digestive Tract Based on Optical Enhanced Endoscopic Technique.
Autorzy:
Song Y; Department of Gastroenterology, People's Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450000 Henan Province, China.
Qu Y; Department of Gastroenterology, People's Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450000 Henan Province, China.
Li L; Department of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou, 450000 Henan Province, China.
Xing M; Xinxiang Medical University, Xinxiang, 453000 Henan Province, China.
Jia B; Department of Critical Care Medicine, Fourth Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, 330000 Jiangxi Province, China.
Ma Y; Department of Gastroenterology, People's Hospital of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, 450000 Henan Province, China.
Zhang Y; Department of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou, 450000 Henan Province, China.
Pokaż więcej
Źródło:
Computational and mathematical methods in medicine [Comput Math Methods Med] 2022 Jul 19; Vol. 2022, pp. 9587070. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022).
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Colorectal Neoplasms*
Esophageal Neoplasms*/diagnostic imaging
Esophageal Neoplasms*/surgery
Stomach Neoplasms*/diagnostic imaging
Stomach Neoplasms*/surgery
Endoscopy ; Humans
Czasopismo naukowe
Tytuł:
Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer.
Autorzy:
Inoo H; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Sakanaka K; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Fujii K; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Ishida Y; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Mizowaki T; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Pokaż więcej
Źródło:
Journal of radiation research [J Radiat Res] 2022 Jul 19; Vol. 63 (4), pp. 646-656.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/complications
Esophageal Neoplasms*/radiotherapy
Radiation Pneumonitis*/etiology
Radiotherapy, Conformal*/adverse effects
Radiotherapy, Conformal*/methods
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/methods
Thoracic Neoplasms*/radiotherapy
Humans ; Organs at Risk ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz